Intervention not reported
Intrapartum and neonatal deaths · nurses, midwives, physicians
The intervention showed no clear difference in intrapartum and neonatal deaths (high certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
High
Intervention not reported
Death from all causes during the · adults with traumatic brain injury
It is very uncertain whether the intervention changes death from all causes during the (very low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether long (> 20 cm) changes death from any cause at day 28 of compared with short (≤ 20 cm) catheter (very low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether surface‐modified changes death from any cause at day 28 of compared with standard double‐lumen catheter with identical geometry and flow design (very low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether CVVHDF changes death from any cause at day 28 of compared with CVVH (very low certainty).
1 finding from 1 review
Adverse events: death (all causes) · idiopathic steroid‐resistant nephrotic syndrome in children
Oral cyclophosphamide showed no clear difference in adverse events: death (all causes) compared with prednisone or placebo (low certainty).
1 finding from 1 review
Adverse event: Death ‐ not measured · people with both severe mental illness and substance misuse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event: Death ‐ not measured · people with both severe mental illness and substance misuse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event: Death ‐ not measured · people with both severe mental illness and substance misuse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal death or serious neonatal perinatal morbidity · women requiring induction of labour
1 finding from 1 review
Serious maternal morbidity or death · women requiring induction of labour
1 finding from 1 review
Neonatal death or serious neonatal perinatal morbidity · women requiring induction of labour
Vaginal misoprostol showed no clear difference in serious neonatal morbidity or death compared with placebo (low certainty).
1 finding from 1 review
Serious maternal morbidity or death · women requiring induction of labour
1 finding from 1 review
Neonatal death or serious neonatal perinatal morbidity · patients with induction of labour at term
1 finding from 1 review
Serious maternal morbidity or death · patients with induction of labour at term
1 finding from 1 review